Drugs & TargetsFree FDA approves therapy for adult patients with blood clotting disorder February 08, 2019Vol.45 No.06
Drugs & TargetsFree Pfizer given positive CHMP opinion for Vizimpro in NSCLC February 08, 2019Vol.45 No.06
Drugs & TargetsFree Genentech submits sBLA for Kadcyla for breast cancer February 08, 2019Vol.45 No.06
Drugs & TargetsFree Merck KGaA and GSK to co-develop immunotherapy M7824 February 08, 2019Vol.45 No.06
Drugs & TargetsFree FDA pursues order to bar some retailers from selling tobacco in efforts to target tobacco use by minors February 08, 2019Vol.45 No.06
Drugs & TargetsFree Alimta + Keytruda and platinum chemo for NSCLC gets FDA label expansion February 01, 2019Vol.45 No.05
Drugs & TargetsFree Trovagene and PoC Capital agree to fund clinical development of onvansertib in metastatic colorectal cancer February 01, 2019Vol.45 No.05
Drugs & TargetsFree European Commission authorizes Rubraca tablets in ovarian cancer January 25, 2019Vol.45 No.04
Drugs & TargetsFree Bristol-Myers Squibb withdraws U.S. application for Opdivo + Yervoy in first-line lung cancer January 25, 2019Vol.45 No.04
